Clinical Trials
- Liver
Mindfulness to treat fatigue in patients with PBC
- Ages18 years - 75 years
- GenderBoth
- Liver
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
- Ages18 years - 75 years
- GenderBoth
- Liver
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PRIMIS)
- Ages18 years - 75 years
- GenderBoth
- Hepatitis, HIV/AIDS, Immune System, Infectious Disease
Screening In Anticipation of Future Research
- Ages2 years - 17 years
- GenderBoth
- Immune System
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
- Ages18 years - 75 years
- GenderBoth
- Liver, Digestive System
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)
- Ages18 years - 75 years
- GenderBoth
- Liver
test
- Ages18 years and older
- GenderBoth